AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Patrys Ltd

0.030

-0.001-3.23%

Volume:1.57M

Turnover:47.03K

Market Cap:20.00M

PE:-3.61

High:0.030

Open:0.030

Low:0.030

Close:0.031

52wk High:0.052

52wk Low:0.015

Shares:666.61M

Float Shares:183.00M

Volume Ratio:13.64

T/O Rate:0.86%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.008

EPS(LYR):-0.008

ROE:-68.25%

ROA:-35.77%

PB:2.16

PE(LYR):-3.61

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Patrys Ltd

Exchange:

ASX

Establishment Date:

2006

Employees:

10

Office Location:

168 Stirling Highway,Ground Floor,Nedlands,Western Australia,Australia

Website:

http://www.patrys.com

Zip Code:

6009

Phone:

Fax:

- -

Introduction:

Patrys Limited, together with its subsidiaries, develops and commercializes antibody technologies for the treatment of cancer in Australia. Its lead technology is Deoxymab 3E10, a DNA damage-repair antibody that penetrates live cell nuclei and inhibits mechanisms of DNA repair in target cancer cells. The company also focuses on developing PAT-DX1 as a treatment for metastatic triple negative breast cancer and glioblastoma. In addition, it engages in developing PAT-SC1's target/antigen CD55PAT-SC1, an isoform of the membrane-bound CD55 for the treatment of gastric cancer. Patrys Limited was founded in 2006 and is based in South Melbourne, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/PAB.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PAB.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PAB.AU\",,,,,undefined,":{"symbol":"PAB.AU","market":"AU","secType":"STK","nameCN":"Patrys Ltd","latestPrice":0.03,"timestamp":1791349920000,"preClose":0.031,"halted":0,"volume":1567603,"delay":0,"changeRate":-0.03225806451612906,"nameEN":"Patrys Ltd","floatShares":183000000,"shares":666613947,"eps":-0.0083,"marketStatus":"Not Yet Opened","change":-0.001,"latestTime":"10-07 16:12:00 AEDT","open":0.03,"high":0.03,"low":0.03,"amount":47028,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.0083,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1791414000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.031,"openAndCloseTimeList":[[1791327600000,1791349200000]],"volumeRatio":13.635409195921074,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"PAB.AU","preClose":0.033,"auctionPrice":0.031,"auctionVolume":15000,"auction":3,"marketStatus":"盘后竞价","timestamp":1790748067272}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PAB.AU\",,,,,undefined,":{"symbol":"PAB.AU","floatShares":183000000,"roa":"-35.77%","roe":"-68.25%","lyrEps":-0.0083,"volumeRatio":13.635409195921074,"shares":666613947,"dividePrice":0,"high":0.03,"amplitude":0,"preClose":0.031,"low":0.03,"week52Low":0.015,"pbRate":"2.16","psRate":"2225.76","week52High":0.052,"institutionHeld":0,"latestPrice":0.03,"eps":-0.0083,"divideRate":0,"volume":1567603,"delay":0,"ttmEps":-0.0083,"open":0.03,"prevYearClose":0.028,"prevWeekClose":0.032,"prevMonthClose":0.031,"prevQuarterClose":0.031,"fiveDayClose":0.031,"twentyDayClose":0.032,"sixtyDayClose":0.038,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PAB.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2025-10-13","symbol":"PAB.AU","defaultRemindTime":1760310000000,"type":"split","dateTimestamp":1760274000000,"forFactor":15,"toFactor":1,"ratio":15},{"market":"AU","date":"2021-11-03","symbol":"PAB.AU","defaultRemindTime":1635894000000,"type":"split","dateTimestamp":1635858000000,"forFactor":995841,"toFactor":1000000,"ratio":0.9958410000000001},{"market":"AU","date":"2020-11-11","symbol":"PAB.AU","type":"split","dateTimestamp":1605013200000,"forFactor":2147483647,"toFactor":2147483647,"ratio":0.99319}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PAB.AU\",market:\"AU\",,,undefined,":[],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":35109071,"yearFounded":2006,"employeeNum":10,"address":"168 Stirling Highway,Ground Floor,Nedlands,Western Australia,Australia","zipCode":"6009","officePhone":"61 8 6165 8858","fiscalYearEnd":"06-30"},"stockCompanyDetail":{"websiteUrl":"http://www.patrys.com","stockEarnings":[{"period":"1week","weight":-0.0606},{"period":"1month","weight":0.0333},{"period":"3month","weight":-0.2051},{"period":"6month","weight":0.24},{"period":"1year","weight":0.0333},{"period":"ytd","weight":0.1071}],"compareEarnings":[{"period":"1week","weight":-0.019},{"period":"1month","weight":-0.0184},{"period":"3month","weight":-0.0203},{"period":"6month","weight":-0.0002},{"period":"1year","weight":0.0612},{"period":"ytd","weight":0.0233}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Patrys Limited, together with its subsidiaries, develops and commercializes antibody technologies for the treatment of cancer in Australia. Its lead technology is Deoxymab 3E10, a DNA damage-repair antibody that penetrates live cell nuclei and inhibits mechanisms of DNA repair in target cancer cells. The company also focuses on developing PAT-DX1 as a treatment for metastatic triple negative breast cancer and glioblastoma. In addition, it engages in developing PAT-SC1's target/antigen CD55PAT-SC1, an isoform of the membrane-bound CD55 for the treatment of gastric cancer. Patrys Limited was founded in 2006 and is based in South Melbourne, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.315789,"avgChangeRate":-0.017041},{"month":2,"riseRate":0.473684,"avgChangeRate":-0.036593},{"month":3,"riseRate":0.263158,"avgChangeRate":-0.038822},{"month":4,"riseRate":0.421053,"avgChangeRate":-0.013545},{"month":5,"riseRate":0.210526,"avgChangeRate":0.005186},{"month":6,"riseRate":0.263158,"avgChangeRate":0.083952},{"month":7,"riseRate":0.15,"avgChangeRate":-0.099452},{"month":8,"riseRate":0.5,"avgChangeRate":0.277246},{"month":9,"riseRate":0.35,"avgChangeRate":-0.007096},{"month":10,"riseRate":0.421053,"avgChangeRate":0.040395},{"month":11,"riseRate":0.210526,"avgChangeRate":-0.026724},{"month":12,"riseRate":0.421053,"avgChangeRate":-0.019673}],"exchange":"ASX","name":"Patrys Ltd","nameEN":"Patrys Ltd"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PAB.AU\",market:\"AU\",,,undefined,":null}}